[CLSTR]
< Back to situations

[ORGANIZATION]

European Respiratory Society

Featured in 34 tracked stories · first seen

Situations

[ACTIVE] [HEALTH] [AT] [US] [DE]

Global shift in youth nicotine consumption trends

12 clusters · 47 sources · last updated

Latest: Disposable e-cigarettes most popular nicotine product among German youth

Research indicates a global shift in nicotine consumption patterns, characterized by a decline in traditional cigarette smoking and a significant rise in the use of electronic cigarettes and vaping products, particularly

[ACTIVE] [HEALTH] [US] [BR] [GB]

GLP-1 drugs: clinical trends, safety, and market shifts

314 clusters · 1157 sources · last updated

Latest: GLP-1 medications and weight management strategies

The clinical and economic landscape of GLP-1 medications continues to expand. Beyond obesity, research indicates potential benefits for psychiatric, respiratory, and neurodegenerative health. Cardiovascular benefits rema

[ACTIVE] [HEALTH] [US] [GB] [SE]

Expanding therapeutic uses and regulatory approvals for GLP-

33 clusters · 154 sources · last updated

Latest: GLP-1 medications show weight loss challenges regarding muscle mass and maintenance

Medical research continues to expand the therapeutic potential of GLP-1 receptor agonists like semaglutide and tirzepatide. While semaglutide is widely used for weight loss and diabetes, new evidence suggests it may slow

[QUIET] [HEALTH] [IT] [BE] [IE]

Depemokimab approval and clinical use in Europe

2 clusters · 21 sources · last updated

Latest: European Commission approves depemokimab for severe asthma

Medical experts initially highlighted the efficacy of depemokimab, a monoclonal antibody targeting interleukin 5 (IL-5), for treating severe eosinophilic asthma and nasal polyposis. During the European Respiratory Societ

[QUIET] [HEALTH] [US] [IN] [MX]

Global second-hand smoke exposure and tobacco control

6 clusters · 73 sources · last updated

Latest: India health experts call for 100% smoke-free public spaces

A global study published in The Lancet Public Health, part of the Global Burden of Diseases research, indicates that approximately 2.71 billion people, or one in three people worldwide, were exposed to second-hand smoke

[QUIET] [HEALTH] [ES] [IT] [PL]

Advancements in respiratory disease research and treatment

2 clusters · 9 sources · last updated

Latest: Biological therapies advance severe asthma treatment in Poland

Medical research and clinical developments are advancing the management of chronic respiratory diseases such as asthma and COPD. Recent studies have identified that the interaction between Aspergillus mold and specific b

[QUIET] [HEALTH] [DE] [TR]

Laughter therapy efficacy for COPD symptoms

2 clusters · 7 sources · last updated

Latest: Laughter therapy may alleviate COPD symptoms

A randomized clinical trial presented at the European Respiratory Society Congress suggests that structured laughter therapy can alleviate symptoms of Chronic Obstructive Pulmonary Disease (COPD). The study, conducted a

Also covered in